Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody (Q73833684)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931119%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931119%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

Voravit Ratanatharathorn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931119%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Lois Ayash

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931119%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Christopher Reynolds

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931119%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Samuel Silver

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931119%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Pavan Reddy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931119%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Michael Becker

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931119%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

James L M Ferrara

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931119%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Joseph P Uberti

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931119%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 August 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931119%20AND%20SRC:MED&resulttype=core&format=json

Biology of Blood and Marrow Transplantation

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931119%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931119%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931119%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

505-511

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931119%20AND%20SRC:MED&resulttype=core&format=json

Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

Chronic graft-versus-host disease: clinical manifestation and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

Advances in transplantation tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

Revisiting graft-versus-host disease models of autoimmunity: new insights in immune regulatory processes

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

Treating human autoimmune disease by depleting B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

Mixed warm and cold autoimmune hemolytic anemia: complete recovery after 2 courses of rituximab treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

Treatment of refractory autoimmune haemolytic anaemia with anti-CD20 (rituximab)

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

Rituximab for idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

Rituximab for myasthenia gravis developing after bone marrow transplant

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

Anti-CD20 monoclonal antibody therapy for autoimmune hemolytic anemia following T cell-depleted, haplo-identical stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

Thalidomide for the treatment of chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

Extracorporeal photochemotherapy for the treatment of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

Systemic sclerosis (scleroderma) and related disorders: clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

Enhanced activation of B cells in a granulocyte colony-stimulating factor-mobilized peripheral blood stem cell graft

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

1 reference

7 January 2021

B cells acquire antigen from target cells after synapse formation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900216-7

7 January 2021

10.1016/S1083-8791(03)00216-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931119%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference